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AbstrAct - Pro-inflammatory cytokines such as interleukin-1    β (IL-1β) and tumor necrosis fac-
tor-alpha (TNF-α) play a key role in the pathogenesis of osteoarthritis (OA). Once released, these 
cytokines are potent stimulators for the de novo production of catabolic enzymes such as matri� metal-
loproteinases (MMPs) and cyclo-o�ygenase-2 (COX-2). Anti-inflammatory agents capable of suppress-
ing the production and catabolic actions of these cytokines may have therapeutic potential in the treat-
ment of OA and a range of other osteoarticular disorders. The purpose of this study was to e�amine the 
therapeutic effect of Curcumin (diferuloylmethane), a pharmacologically safe phytochemical agent, on 
males and foals affected by degenerative joint diseases. Curcumin, in the form phytosome (CURCU-
VET®, Indena Spa, Milan, Italy) was administered to animals for fifteen days and gene e�pression was 
monitored before the treatment and after four, eight, and fifteen days. In mares, Curcumin inhibited 
the e�pression of COX-2, TNF-α, IL-1β, IL1RN, and IL��, even if only the downregulation of IL-1β and 
IL1RN were significant. In foals, Curcumin significantly inhibited the e�pression of COX-2, TNF-α, 
IL1RN and significantly increased that of IL��. These results indicate that Curcumin has nutritional 
potential as a natural anti-inflammatory agent for treating osteoarticular disorders through suppres-
sion of pro-inflammatory cytokines and catabolic enzymes.
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Introduction - Osteoarthritis (OA) is a well-known and common disease for the athletic horse 
and seriously affects the quality of life and career of affected animals, leading to economic losses. 
Among the causes of OA, joint disease is very frequently diagnosed (Todhunter and Lust, 1����0). Also 
in growing horses, articular osteochondrosis is a major joint pathology with high prevalence and im-
portant economic impact (Gangl et al., 2007). The onset of disease begins as an abnormal chondrocyte 
development and maturation, leading to altered endochondral ossification and subsequent damage to 
the cartilage, resulting in osteochondral lesions or fragmentation and incongruency of the articular 
cartilage (Jeffcott and Henson, 1����8). It is known that articular cartilage is a metabolically active tis-
sue and that chondrocytes are able to synthesize and digest matri� macromolecules, thus contributing 
to cartilage matri� homeostasis. In OA, the equilibrium between matri� deposition and degradation is 
disrupted, leading to the e�cessive digestion of matri� and progressive loss of important matri� com-
ponents. Even in the absence of classic inflammation, elevated levels of inflammatory cytokines have 
been measured in OA synovial fluid, including interleukin-1β (IL-1β), interleukin �� (IL��), transform-
ing growth factor-β (TGF-β), and tumor necrosis factor-alpha (TNF-α) (Islam et al., 2001). Inflamma-
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tory cytokines, as TNF-α and IL-1β, have also been shown to induce e�pression of metalloproteases 
(MMPs) (Mengshol et al., 2002) and cyclo-o�ygenase-2 (COX-2). These synovium and chondrocyte-de-
rived products represent potential targets for the development of therapeutic agents, which could be 
used to prevent or retard the progression of the OA articular lesion. Chronic arthritis and pain associ-
ated conditions are the most common conditions for which Non-Steroidal Anti-Inflammatory Drugs 
(NSAIDs) are used. However, NSAIDs have well-known adverse effects, including gastric ulceration 
and inhibition of cartilage resynthesis without reducing inflammation-associated cartilage break-
down. For these reasons, alternatives to allopathic medications, as nutraceuticals and complementary 
therapies, are often sought for arthritic conditions in horses and companion animals. In this study, the 
bioactivity of CURCUVET® (Indena Spa, Milan, Italy), a Curcuma longa stabilized e�tract associated 
to a phytosome comple�, was investigated in 12 subjects, including 7 mares affected by osteoarthritis 
and � foals affected by osteocondhrosis. The effect was evaluated by measuring the e�pression levels 
of a set of genes associated to inflammatory cascade. 
Material and methods - Seven adult mares (4-�� years) affected by chronic osteoarthritis and five 
foals affected by osteochondrosis were used for the study. The diagnosis was based on clinical signs 
and radiological e�amination, e�ecuted by the veterinary. The animals received 4 mg/kg LW of CUR-
CUVET® every 24 hours before the morning meal for 1� consecutive days. Blood was collected from 
jugular vein in the morning before (T0) and after the CURCUVET® treatment, specifically on days 4, 
8, and 1� (T1, T2, and T� respectively) from the beginning of the trial. Blood was sampled after 2 hours 
from the CURCUVET® administration. 
Whole blood (2.� ml) was drawn directly into a PAX gene blood RNA tube (PreAnalyti�, Qiagen, 
Cologne, Germany) and total RNA was purified with PAX gene blood RNA kits (PreAnalyti�, Qiagen) 
according to the manufacturer’s protocols. Reverse transcription was performed by using Improm-II 
Reverse Transcriptase (Promega, Milan, Italy) according to the manufacturer’s instructions. Real-
Time PCR reactions were performed in triplicate using Platinum® SYBR® Green qPCR SuperMi�-
UDG (Invitrogen, Milan, Italy). Oligonucleotide primers were designed with the help of Primer� Input 
software (Rozen and Skaletsky, 2000). Target gene were COX-1, cyclo-o�ygenase-1; COX-2, cyclo-o�y-
genase-2; TNF-α, tumor necrosis factor-alpha; IL1β, interleukin 1β; IL1RN, interleukin 1 receptor 
antagonist; IL��, interleukin ��. As reference housekeeping gene, 18S rRNA (18S ribosomal RNA) was 
used. The e�pression level of a given target gene at each sampling time, was analyzed by the 2-ΔΔCt 
method (Bustin, 2000) where 2-ΔΔCt represents the different regulation of a given target gene at T1, T2, 
or T� vs. the T0. The n-fold e�pression was calculated as 2-ΔΔCt for upregulated genes, and – (1/2-ΔΔCt) 
Figure 1.  Effect of CURCUVET® administration on the expression level (n-fold) of 
a set of genes of the inflammatory cascade in mares (A) and foals (B); 
*P<0.05, $P<0.1.
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for downregulated genes. All the recorded variables were submitted to analysis of variance using the 
ANOVA model to assess significant differences between sampling times (SPSS Inc., 1����7). 
results and conclusions - The treatment of mares with CURCUVET® induced a down regula-
tion of COX-2, TNF-α, IL��, IL-1β and IL1RN, even if the effect was significant only for the last two 
genes (Figure 1). In particular, IL-1β gene e�pression was reduced at T2 andT� (P<0.0�), whereas 
IL1RN gene e�pression only at T� (P<0.1). In foals treated with CURCUVET®, COX-1, COX-2, TNF-α, 
IL-1β, IL1RN resulted downregulated, even if the effect was significant only for COX-2, TNF-α, IL1RN. 
COX-2 transcription was reduced only at T� (P<0.0�), whereas TNF-α (P<0.0�) and IL1RN (P<0.0�) 
transcription diminished at T1, T2, and T�. Differently, IL�� gene e�pression resulted significantly 
upregulated at T1, T2, and T� (P<0.0�). The stimulation of IL�� e�pression could have a beneficial 
effect since IL�� has a protective role with respect to cartilage integrity (Goldring, 2000). Moreover, 
during the inflammatory response, IL�� has a regulatory effect inhibiting IL-1β and TNF-α e�pression 
(Feghali and Wright, 1����7). These results are in agreement with previous studies showing that Cur-
cumin inhibit IL-1β levels (Banerjee et al., 200�), and IL-1β and TNF-α stimulated activity of NFkB 
(Nuclear Factor kB) and downstream targets, such as COX-2 and MMP�� (Matri� Metallopeptidase 
��) (Shakibaei et al., 2007). These results indicate that CURCUVET® has nutritional potential as an 
anti-inflammatory agent for treating osteoarticular disorders through suppression of pro-inflamma-
tory cytokines and catabolic enzymes. 
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